Liabilities / Assets
52nd percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
10th percentile
Higher net margin than 10% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
8th percentile
Faster asset growth than 8% of similar nonprofits.
Revenue Growth
24th percentile
Faster revenue growth than 24% of similar nonprofits.
Balance Sheet
Assets
Down$27,474
Down $31,178 (-53%) from 2019
Net Assets
Down$27,474
Down $31,178 (-53%) from 2019
Liabilities
Down$0
Down $52 (-100%) from 2019
Revenue And Expenses
Revenue
Down$46,229
Down $40,334 (-47%) from 2019
Expenses
Up$77,354
Up $44,433 (+135%) from 2019
Net Income
Down-$31,125
Down $84,767 (-158%) from 2019
Historical Trend
Filing Detail Status
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview
Mission
Advance research & patient support for rare blood cancers
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2020 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $27,474
- Liabilities
- $0
- Net assets
- $27,474
- Revenue
- $46,229
- Expenses
- $77,354
- Net income
- -$31,125